Research Article

Analytical Method Validation of Gamijakyakgamchobuja-Tang (KCHO-1, Mecasin) Preparation

Table 10

Stability of the dosing formulations for 7 days under refrigeration.
(a) Curcumin

DayConcentration of the dosing formulation (μg/mL)Measured concentration Mean (μg/mL)SDCV (%)Accuracy (%)Variation (%)
(μg/mL)
No.1No.2No.3

039.546.5245.7946.3346.210.380.82116.99-
158.0186.52180.49184.37183.793.061.66116.32-

739.537.9238.6536.5737.711.062.8095.48-18.39
158.0143.93152.77152.53149.745.043.3794.77-18.53

(b) Glycyrrhizic Acid

DayConcentration of the dosing formulation (μg/mL)Measured concentration Mean (μg/mL)SDCV (%)Accuracy (%)Variation (%)
(μg/mL)
No.1No.2No.3

0305.0234.75240.17244.67239.864.972.0778.64-
1220.0961.40959.78971.12964.106.130.6479.02-

7305.0277.24273.06264.09271.466.722.4889.0013.18
1220.01099.671165.431119.481128.1933.732.9992.4717.02

(c) Salvianolic Acid B

DayConcentration of the dosing formulation (μg/mL)Measured concentration Mean (μg/mL)SDCV (%)Accuracy (%)Variation (%)
(μg/mL)
No.1No.2No.3

0985.0932.67944.18948.37941.748.130.8695.61-
3940.03762.213675.213755.963731.1348.531.3094.70-

7985.0996.37991.24955.72981.1122.142.2699.614.18
3940.03879.514111.823986.463992.60116.282.91101.347.01